• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Italy Pharmaceuticals and Healthcare Report Q1 2011 - Product Image

Italy Pharmaceuticals and Healthcare Report Q1 2011

  • ID: 1546899
  • November 2010
  • Region: Italy
  • 80 Pages
  • Business Monitor International


  • GlaxoSmithKline
  • Menarini
  • Merck & Co
  • Novartis
  • Pfizer
  • Recordati
  • MORE

Italy Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Italy's pharmaceuticals and healthcare industry.

In BMI's Q111 Pharmaceuticals & Healthcare Business Environment Ratings (BERs), the Western Europe region scored a total of 64.4 out of 100. The attractiveness of the region to pharmaceutical firms stems from the fact that its countries are key revenue sources for 'big pharma', particularly for companies selling high-end products, as per-capita spending is substantially higher than in emerging markets. However, it is BMI's view that drug companies will face many challenges in Western Europe over the next decade. Our view is underpinned by the poor state of public finances across the eurozone economy, which will see the largest economies undergo prolonged fiscal adjustments in addition to the patent cliff, added regulatory hurdles and increasingly scrupulous cost-effectiveness assessments of new drugs – all factors that will influence the risk and reward scores assigned to markets READ MORE >


  • GlaxoSmithKline
  • Menarini
  • Merck & Co
  • Novartis
  • Pfizer
  • Recordati
  • MORE

Executive Summary

SWOT Analysis
Italy Pharmaceuticals And Healthcare Industry SWOT
Italy Political SWOT
Italy Economic SWOT

Pharmaceutical Business Environment Ratings
Table: Western Europe - Regional Business Environment Ratings, Q111

Italy – Market Summary

Regulatory Regime
Table: Italy – Examples of Pharmaceutical Status Switches
Intellectual Property Developments
Counterfeit Pharmaceuticals
Pricing Regime
Reimbursement Regime

Industry Developments
Table: Disease Burden In Western Europe
Healthcare Sector
Healthcare Financing
Pharmaceutical Wholesale Sector
Retail Pharmacy Sector
Clinical Trials
Medical Devices
Recent Activities in the Medical Devices Industry

Industry Forecast Scenario
Overall Market Forecast
Table: Pharmaceutical Sales Indicators 2006-2014
Key Growth Factors – Industry
Table: Healthcare Expenditure Indicators 2006-2014
Table: Government Healthcare Expenditure Indicators 2006-2014
Table: Private Healthcare Expenditure Indicators 2006-2014
Key Growth Factors – Macroeconomic
Table: Italy – Economic Activity
Prescription Drug Market Forecast
Table: Top 10 Active Pharmaceutical Ingredients By SSN Expenditure
Table: Prescription Drug Sales Indicators 2006-2014
Patented Drug Market Forecast
Table: Patented Drug Market Indicators 2006-2014
Generic Drug Market Forecast
Table: Generic Drug Sales Indicators 2006-2014
OTC Medicine Market Forecast
Table: OTC Medicine Sales Indicators 2006-2014
Medical Device Market Forecast
Table: Medical Devices Sales Indicators 2006 - 2014
Pharmaceutical Trade Forecast
Table: Pharmaceutical Export & Import Indicators 2006-2014
Other Healthcare Data Forecasts
Key Risk to BMI’s Forecasts

Competitive Landscape
Pharmaceutical Industry
Leading Local Healthcare Companies According To Market Capitalisation
Recent Company Developments

Company Profiles
Indigenous Manufacturers
Leading Multinational Manufacturers
Merck & Co

Country Snapshot: Italy Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education and Healthcare
Table: Education, 2002-2005
Table: Vital Statistics, 2005-2030
Section 3: Labour Market and Spending Power
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2000-2012 (US$)
Table: Average Annual Manufacturing Wages, 2000-2012

BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Risk/Reward Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Table: Weighting Of Components

- Recordati
- Menarini
- GlaxoSmithKline
- Pfizer
- Novartis
- Sanofi-Aventis
- Merck & Co

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos